Stanford Medicine researchers discovered that subtle patterns of resting brain activity can predict Alzheimer’s disease progression years before memory problems appear. The study, published in Science Advances, mapped Alzheimer’s brain signals across resting neural networks, showing how communication between separate brain regions separates cognitive resilience from early decline. By comparing healthy older adults who possess exceptional memory with patients diagnosed with dementia, the team built a scoring model that identified future memory decline in middle-aged adults tracked for up to 12 years [2].
Predicting Risk Before Memory Loss
Two people can walk into a clinic today, take the same standard memory assessment, and earn identical scores. Their initial test scores match. Years later, one person might struggle with everyday routines and appointments while the other keeps sharp memory and executive skills. Why do two people with identical memory test scores face such divergent cognitive paths years down the road? Researchers at Stanford Medicine suspected that the earliest clues to that difference lie inside how distant brain regions communicate while a person rests quietly [3].
Most clinical investigations into Alzheimer’s disease focus on well-known molecular markers such as amyloid-beta plaques and tau tangles. While these proteins remain essential for confirming disease pathology, they typically accumulate during later stages when neural circuits have already suffered harm. Yu Zhang, PhD, assistant professor of psychiatry and behavioral sciences at Stanford Medicine and senior author of the study, focused on early detection tools. “What we really care about is defining early markers that can detect earlier signs of cognitive decline and potentially help us deliver timely interventions to people,” Zhang said [2].
While earlier clinical investigations documented how muscle loss with age signals dementia risk through physical frailty and declining bodily strength, the Stanford Medicine project examined whether functional communication between distant brain regions could reveal neurodegenerative vulnerability before physical or cognitive symptoms emerge. Identifying resilient brain signatures could help clinicians intervene before irreversible cell loss occurs. Zhang noted that future therapies might use cognitive training or magnetic stimulation to steer vulnerable brain circuits back toward healthier communication patterns [2].
Mapping Alzheimer’s Brain Signals at Rest
To observe functional communication across the brain, researchers used resting-state functional magnetic resonance imaging (fMRI). This noninvasive scanning method tracks subtle changes in blood oxygen levels as an indirect measure of neural signaling while an individual lies still in the scanner. Scientists examine these scans to pinpoint regions whose signals rise and fall in synchrony, a network map known as the functional connectome [3].
Previous aging studies often compared exceptional older adults with typical peers who showed normal cognitive performance for their age. Zhang realized that this method overlooked meaningful biological differences because seemingly healthy older individuals form a biologically mixed group. Some typical adults already carry silent amyloid-beta accumulation, whereas others do not. Both groups looked healthy on paper. To create a clearer comparison, the Stanford team examined 180 SuperAgers and 110 older adults diagnosed with Alzheimer’s disease who were of similar age [2].
Comparing scans from these two opposing groups revealed clear differences in how brain regions communicated. Connections involving the front of the brain were stronger in SuperAgers, while connections involving the insula, tucked deep inside the brain, were stronger in people with Alzheimer’s disease. By tracking these Alzheimer’s brain signals, the researchers built an objective map of cognitive vulnerability. “This suggests that Alzheimer’s vulnerability may be reflected in how the brain functions as an interconnected system,” said Kanhao (Alex) Zhao, PhD, a postdoctoral scholar in psychiatry at Stanford Medicine and lead author of the study [3].
The SuperAger Brain
Depending on how researchers define the group, roughly 10% of older adults qualify as super agers. In this study, the term referred specifically to individuals at least 75 years old who scored on memory tests at a level typical of a 45-year-old while keeping normal executive function for their age. Most earlier research struggled to separate protective brain traits from normal aging because standard control groups were too heterogeneous. “Normal, cognitively unimpaired individuals are pretty heterogeneous in terms of their biological abnormalities,” Zhang said. “Simply comparing super agers with such a heterogeneous population makes it challenging to define what is critical in terms of resilient or vulnerable brain patterns”. By contrasting SuperAgers against Alzheimer’s patients, the team identified the specific network connections that distinguish resilient brains from failing ones [2].
Using these differences in neural communication, the Stanford investigators created a measurement called the Alzheimer’s Resilience-Vulnerability Connectome, or ARC score. In their discovery group of 290 older adults, the Alzheimer’s Resilience-Vulnerability Connectome distinguished SuperAgers from Alzheimer’s patients with an area under the receiver operating characteristic curve of 0.85, reaching roughly 85% classification accuracy across resting-state networks [1, 2]. When the team tested the scoring system on an independent replication cohort of 143 individuals who already belonged to one of the two groups, the model placed about 71 percent into the correct category [1, 3].
Tracking Alzheimer’s Brain Signals Over Time
Having established the scoring model, the researchers examined whether ARC scores could predict the cognitive future of people whose memory remained intact. They applied the scoring system to baseline brain scans from 1,315 cognitively healthy adults between the ages of 55 and 70 [2, 3]. These scans were gathered from major public datasets, including the Open Access Series of Imaging Studies, the Harvard Aging Brain Study, and the Alzheimer’s Disease Neuroimaging Initiative (ADNI) [1, 2]. At the beginning of the study, participants with low and high ARC scores performed similarly across standard memory and thinking assessments [2, 3].
Over time, however, clear differences emerged between the two groups. Follow-up records tracked their memory. Most participants were followed for five to six years, while some had records extending up to 12 years [2, 3]. Adults with higher, Alzheimer-like ARC scores experienced faster decline on tests of memory, attention, and executive function. They were also more likely to develop mild cognitive impairment or Alzheimer’s disease during follow-up [2, 3]. “We used the ARC score to make a prediction of how likely this patient will convert into mild cognitive impairment or Alzheimer’s disease,” Zhao said [2].
People with lower ARC scores, whose brain activity looked more like SuperAgers, maintained their cognitive abilities and avoided steep memory loss. Tracking Alzheimer’s brain signals across these multi-year datasets showed that functional connectivity could identify risk earlier than conventional cognitive testing. The researchers also compared ARC scores with brain age, a metric that estimates neurological aging from healthy MRI data. While the two measurements correlated, Zhang explained that ARC provides more targeted information about whether a brain is vulnerable or resistant to cognitive decline [2].
Biological Clues and Genetic Links
Follow-up brain scans showed that amyloid-beta protein accumulated faster in people who began the study with Alzheimer-like ARC scores, even though both groups had similar protein levels at baseline. Interestingly, the researchers found no clear variation between the groups in the buildup of tau, another hallmark protein linked to Alzheimer’s pathology. People with SuperAger-like scans were also younger on average, but an additional analysis confirmed that differences in cognitive performance and clinical ratings persisted after adjusting for age [3].
Statistical modeling confirmed that adding ARC scores improved clinical risk predictions beyond what investigators could forecast using chronological age, amyloid-beta accumulation, tau tangle deposition, and established genetic susceptibility linked to the apolipoprotein E (APOE) gene [3]. In exploratory genome-wide association analyses, the research team also identified CLYBL and FRMD6 as candidate genetic loci linked to the connectome subtype differences. These Alzheimer’s brain signals appear to capture a continuous biological dimension of cognitive aging that spans resilient SuperAgers, typical aging adults, and people developing dementia [1].
Many neuroscientists still debate whether modern biological clues can help medicine fully understand dementia before structural brain damage takes place. Zhao said that while these findings are encouraging, the ARC scoring model is not ready for routine clinical care. “We would need larger prospective studies following cognitively healthy individuals over several years, with validation across diverse populations and MRI scanners,” Zhao said. “These studies must establish reliable individual-level predictions, demonstrate added value beyond existing biomarkers, and determine whether ARC-informed assessments improve clinical decisions” [3].
Can Brain Activity Be Retrained?
Stanford researchers point out that an ARC score is not a permanent verdict on a person’s cognitive future. Brain activity patterns naturally fluctuate, and an individual who shows a resilient pattern in early old age may not keep it indefinitely. For example, the proportion of adults displaying SuperAger-like connectivity tends to decline as people grow older, while head injuries or neuropsychiatric conditions can alter network signaling. Because brain connectivity can shift in both directions, Zhang believes targeted interventions might nudge vulnerable circuits back toward resilient communication [2].
Potential therapies include cognitive training and transcranial magnetic stimulation, a technique that delivers gentle magnetic pulses to modify neural circuits and is already used to treat depression. Zhang’s laboratory is preparing a clinical trial to measure ARC scores before and after cognitive training, testing whether guided mental exercises can move brain activity toward healthier patterns. Researchers from Children’s National Hospital, the University of Texas at Austin, Lehigh University, Penn State College of Medicine, New York University Grossman School of Medicine, and the University of California, Los Angeles contributed to the study. Support came from the National Institutes of Health, the Rosenkranz Foundation-Knight Initiative program, the Alzheimer’s Association, and a Lehigh University CORE grant [2].
- ACADEMIC JOURNAL Zhao, K., Xie, H., Fonzo, G. A., Carlisle, N. B., Jacobs, T., Osorio, R. S., Church, A., Lin, F. V., & Zhang, Y. (2026). A functional connectome identifies vulnerability to cognitive decline and Alzheimer’s disease progression. Science Advances, 12(45). [Article Link]
- ONLINE NEWS Stanford Medicine. (2026, November 14). Stanford scientists discover hidden brain signals that predict Alzheimer’s years before symptoms. ScienceDaily. [Article Link]
- ONLINE NEWS Öz, E. (2026, November 14). Stanford scientists discover resting brain activity may predict Alzheimer’s years before memory decline. ScienceAlert. [Article Link]
APA 7: PerEXP Teamworks. (2026, November 15). Stanford Maps Alzheimer’s Brain Signals Before Memory Loss. PerEXP Teamworks. https://perexpteamworks.com/en/alzheimers-brain-signals-mapped-stanford/
